Innervace

Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders Series A financing round, led by Deerfield Management, to accelerate a new cell therapy modality for the treatment of neurological disorders, including Parkinson’s Disease See more here